Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Faced with high burn from rapid sales with slow reimbursement, Guardant throttled its sales team. The co-CEO now calls this the 'wrong decision,' as it halted momentum, cost them significant market share, and gave competitors time to catch up.

Related Insights

Paradoxically, once a startup finds product-market fit, a major failure mode is not scaling aggressively enough. Founders who stay too lean and delay executive hires risk being overtaken by competitors who capitalize on the opportunity and scale faster.

In the run-up to its IPO, Snowflake slowed hiring to optimize for profitability. This caused the sales team to focus on easier upsells from existing accounts (with 177% net retention) instead of new business. As a result, they neglected new logo acquisition for two years, hurting long-term growth.

Initially seen as a distraction, pharma partnerships became a source of high-margin, non-dilutive capital for Guardant. More importantly, buying signals from pharma served as a leading indicator for future clinical demand, de-risking their product roadmap.

As Eleven Labs shifted to enterprise, the long 6-12 month sales cycles caused skepticism among its fast-paced PLG teams. To maintain morale, leadership had to actively shield the teams from the lengthy process, asking for trust until the enterprise deals began to materialize and prove the strategy.

While seen as a "COVID darling," the massive influx of business made the company complacent. The sales team shifted to order-taking, and engineering focused solely on scaling, effectively halting the product innovation engine that the new CEO had to restart.

After raising $35M, Legora's founder halted sales for six months to address scalability issues. Despite VC pressure, he correctly identified that onboarding prestigious clients to a faulty product would burn their reputation and kill long-term growth, a risk greater than a temporary sales pause.

At Cursor, explosive PLG growth meant salespeople were "drowning in opportunity," only converting existing credit card users. This reactive motion prevents proactive, strategic selling, risking long-term market capture. Success itself becomes the biggest threat.

When a business stalls, leadership often defaults to blaming the sales team. However, growth is a system. The root cause may lie in poor marketing positioning, a dated website, or a customer success function that is reactive support rather than proactive expansion. A holistic diagnosis is required.

Rapid sales growth creates a powerful "winning" culture that boosts morale and attracts talent. However, as seen with Zenefits, this positive momentum can obscure significant underlying operational or ethical issues. This makes hyper-growth a double-edged sword that leaders must manage carefully.

While many product-led growth companies delay building a sales team, this is often a mistake. Waiting until bottoms-up growth stalls forces a painful "whiplash moment" as the company scrambles to adopt a new GTM motion. Building both motions in parallel creates a more resilient business.

Guardant Lost 18 Months of Market Share By Throttling Growth During a PMF Surge | RiffOn